Sudarshan Chemical Q3 Profit Plunges, FY26 Guidance Cut Amid Demand Slump

CHEMICALS
Whalesbook Logo
AuthorAkshat Lakshkar|Published at:
Sudarshan Chemical Q3 Profit Plunges, FY26 Guidance Cut Amid Demand Slump
Overview

Sudarshan Chemical Industries reported a challenging Q3 FY26, with revenue at ₹1,683 Cr and adjusted EBITDA at ₹77 Cr (11.8% margin). The nine-month period saw a 0.4% revenue dip and a stark 74% fall in adjusted EBITDA to ₹66 Cr, leading to a ₹157 Cr PBT loss. Management cited weak pigment demand and high inventory levels but expressed optimism for recovery. The integration of Heubach is progressing, with cost savings identified, but FY26 EBITDA guidance for the acquired group was lowered. A key strategy is reducing finished goods inventory by €30-40 Mn, aiming to bolster cash flow and reduce debt, though it may temporarily impact reported EBITDA.

📉 The Financial Deep Dive

Sudarshan Chemical Industries Limited has unveiled a set of quarterly and nine-month financial results for the period ending December 31, 2025 (Q3 FY26) that highlight significant headwinds in the pigment sector.

The Numbers:

  • Q3 FY26: Consolidated revenue from operations reached ₹1,683 Cr. Adjusted EBITDA stood at ₹77 Cr, translating to an EBITDA margin of 11.8%. Profit Before Tax (PBT) for the quarter was ₹6 Cr.
  • 9M FY26: Revenue declined marginally by 0.4% YoY to ₹1,988 Cr. However, the impact on profitability was severe, with Adjusted EBITDA plummeting 74% YoY to ₹66 Cr, resulting in a drastically lower EBITDA margin of 1.3%. The company reported a substantial PBT loss of ₹157 Cr for the nine-month period.
  • Balance Sheet: Net debt has risen to ₹1,123 Cr as of 9M FY26. The Adjusted Return on Capital Employed (ROCE) for the nine months was 6.0%.
  • Guidance Cut: The outlook for the acquired Heubach group's FY26 EBITDA has been revised downwards to approximately €16 Mn, from an earlier guidance of €25 Mn.

The Quality & The Grill:

Management attributed the subdued performance to continued low demand across key pigment end-use industries like coatings and plastics, citing high interest rates and subdued economic growth. Elevated customer inventory levels and tariff challenges further compounded these issues. Despite these negative factors, management expressed a cautiously optimistic view, stating that "the worst is behind us" and anticipating a market recovery, with early signs of easing destocking and improved purchasing emerging.

A significant strategic initiative is the planned reduction of finished goods inventory by an estimated €30-40 Mn over the next three quarters. While this move is expected to positively impact operating cash flows and strengthen the balance sheet by reducing working capital and net debt, it is flagged to temporarily impact reported EBITDA due to the release of capitalized overheads. This inventory reduction, coupled with the downward revision of Heubach's EBITDA guidance, presents near-term challenges for reported profitability metrics.

Risks & Outlook:

The primary risks revolve around the pace of market recovery, the successful execution of the inventory reduction strategy without further operational disruptions, and the realization of integration synergies from the Heubach acquisition. The increasing net debt also warrants close monitoring. Investors should watch for signs of sustained demand improvement and the company's ability to manage its working capital efficiently while navigating the temporary EBITDA impact from inventory adjustments. The long-term direction appears focused on leveraging the integrated Heubach business and optimizing the balance sheet.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.